As the team of researchers from the University of Adelaide and the Basil Hetzel Institute at Adelaide's Queen Elizabeth Hospital used a combined vaccination approach in conducting the study, researcher Dr. Branka Grubor-Bauk have recently announced that the progress toward vaccinating people against HIV infection is heading through the right path. It was found that Australian scientists have come up with a right approach to creating a vaccine for the deadly virus. It was said that the findings have been published in Nature's journal, Scientific Reports.
How Did The Study Arrive At Their Conclusion?
In one of the team's statements released by ABC News, after a long four years of study, Dr. Grubor-Bauk explained that a common-cold virus has been used in order to introduce the vaccine to the human body, and a DNA-based vaccine injected to help the immune system work at the most common sites of HIV infection, the gut and body cavities.
In conducting the study, Zee News has revealed that the team has targeted the vaccine into areas in which the HIV infection is most commonly found, and discovered that the testing achieved a "significant reduction" of infection rates in the mice. The team has also highly emphasized that in the course of their study, they were also able to create this common cold virus that encoded proteins of HIV and we vaccinated mice and we were successful in creating immunity in mucosal surfaces.
Currently, the WHO and UNAIDS has revealed that at the end of 2015, there were approximately 36.7 million people living with HIV across the globe, some 2.1 million people became newly infected, and 1.1 million has already died of HIV-related causes. Furthermore, Dr. Grubor-Bauk has also added that now that their team has made a landmark discovery, it is just but vital that the research continues into a human vaccine for the HIV infection.
